Guardant Health Inc. (5GH)
FSX
Closed
Oct 8, 2026
Day's Range
149.2852 wk Range
52.94Overview - 5GH - Guardant Health Inc.
Key Statistics
Valuation
Enterprise Value
18.99B
P/E (Trailing)
‪-47.14‬
P/E (Forward)
‪-46.44‬
PEG Ratio
‪-3.77‬
Price / Sales (TTM)
‪17.75‬
Price / Book
‪-93.31‬
EV / EBITDA
‪-50.27‬
Profitability
Gross Margin
‪65.38%‬
Profit Margin
‪-38.32%‬
Operating Margin
‪-38.24%‬
Return on Assets
‪-18.07%‬
Return on Equity
‪419.18%‬
Ownership
Shares Outstanding
133.61M
Float
129.47M
Held by Insiders
‪3.96%‬
Held by Institutions
‪100.90%‬
Price stats
Beta
‪1.57‬
50-Day Avg
‪140.72‬
200-Day Avg
‪105.29‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 5GH - Guardant Health Inc.
Peers - 5GH - Guardant Health Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on FSX.
Profile Summary - 5GH - Guardant Health Inc.
About
Guardant Health Inc. is a precision oncology company that develops blood- and tissue-based tests, data sets, and analytics to support cancer detection and treatment decisions. Its product portfolio includes liquid biopsy tests for tumor mutation profiling, molecular residual disease monitoring, tissue-based genomic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
